Dr. Samuel Henderson, Accera's V.P. of Research and Development, to Present at the 249th American Chemical Society National Meeting
February 20, 2015
Presentation is entitled: Induced ketosis in mild to moderate Alzheimer's disease
BROOMFIELD, CO., Feb 10, 2015 (PRNEWSWIRE) – Accera, Inc, a leader in the development of new therapies to treat neurological disorders, today announced that Dr. Samuel Henderson, Accera's Vice President of Research and Development, will present a review of the company's technology at the 249th American Chemical Society National Meeting that will be held in Denver, Colorado, March 22-26, 2015.
The presentation entitled, "Induced ketosis in mild to moderate Alzheimer's disease" will take place in the Colorado Biotechnology Session at 10:10-10:50am on Sunday, March 22nd in the Mt. Sopris Room at the Grand Hyatt Denver.